Openbookopenbook
Equity
Eckert & Ziegler Strahlen- und Medizintechnik AG(0NZY)
EUR --+0.00%
Reward69High
Risk30Moderate
📊75%Data
Strong 16% profit margin
0NZY
+0.0 · +0.00%
EUR · LSE
Eckert & Ziegler Strahlen- und Medizintechnik AG |
Quality Compounder
Market Cap:203.35M
ℹ️
Reward Rating
69
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
30
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0NZY to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Eckert & Ziegler Strahlen- und Medizintechnik AG?

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally.

0NZY · Verdict

Solid reward · low risk

0NZY stands out on balance sheet and cash flow, but watch the volatility signal.

Based on 88% data coverage

0NZY · Verdict

What’s working & what to watch

Strengths 5

  • Balance sheet99/100

    Interest covered 38.7×

  • Cash flow89/100

    11% free-cash-flow margin

  • Profitability76/100

    16% net margin · 21% ROE

  • Growth75/100

    Rev +12.0% CAGR · earnings +18.5%

  • Valuation75/100

    Above average

Watchouts 1

  • Volatility20/100

    Weak vs peers

Model-based scoring. For information only — not financial advice.

What is Eckert & Ziegler Strahlen- und Medizintechnik AG?

Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company is listed on the LSE in UK, with a market capitalisation of 203.35M, and a P/E ratio of 0.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Strong margins and consistent earnings support financial stability.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: High (69)

The scoring profile indicates moderate reward potential, with profitability and growth as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap203.35M
P/E Ratio0.305
Dividend Yield0.55%
52 Week High23.0666
52 Week Low13.32
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding5M
No. of Employees1,116
IndustryN/A
ExchangeLSE
Beta1.544
CurrencyEUR
Websitewww.ezag.com
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.